chr4-110618690-T-C
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000325.6(PITX2):c.412-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000325.6 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PITX2 | NM_000325.6 | c.412-2A>G | splice_acceptor_variant, intron_variant | Intron 2 of 2 | ENST00000644743.1 | NP_000316.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Axenfeld-Rieger syndrome type 1 Pathogenic:1
- -
Anterior segment dysgenesis 4;C3714873:Axenfeld-Rieger syndrome type 1 Pathogenic:1
In summary, this variant is a novel splice site variant that is expected to disrupt an important protein binding domain. This evidence indicates that the variant is pathogenic, but additional data is needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant is expected to disrupt the functionally conserved OAR or aristaless domain, which is located in the final 39 amino acids of the PITX2 protein. This domain mediates the interaction with a number of proteins that are required for PITX2 transcriptional transactivation activity (PMID: 10490637, 18045789, 15728254). In addition, a different variant affecting this splice acceptor site (c.253-1G>A) has been reported in 2 individuals affected with Axenfeld-Rieger syndrome (PMID: 22569110). This suggests that this splice site is critical for PITX2 protein function, and that other variants that affect this splice site may also be pathogenic. This variant has not been reported in the literature in individuals with a PITX2-related disease. This sequence change affects an acceptor splice site in the last intron (intron 4) of the PITX2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 187 amino acids of the PITX2 protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at